about us

press release

contact

Home

Executives

Acquisitions/Mergers

Funding

FDA Updates

Clinical Trials

Medical Device News

Past News

Accuredit Therapeutics and N1 Life Form a Joint Venture Named ‘Napoltec’, Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical...

"We are very pleased to establish a new joint venture, Napoltec, with N1 Life, which will be featuring complementary in mutually pursuing gene therapy drug development. The N1 Life team led by Dr. Zang and Prof. Wender has accumulated years of research and development experience in novel delivery systems.

Hekka Labs Introduces the First Decentralized Chronic Disease Data Management Ecosystem in South Asia

Hekka has cemented initial partnerships with 3 Indian healthcare solution providers, Curisin, a healthcare company with a wide network of 30 million patients and 40,000 partnered doctors which as recently agreed to provide a minimum of 1.5 million medical records in 2022.

Impact NRS LLC Creates RumenEra Inc to Develop and Commercialize High-Impact Rumen Microbiome Applications in a Joint Collaboration with National Institute for Biotechnology in...

Mr. Salman continues "RumenEra is committed to the creation of a global reference standard for the rapid measurement of net feed efficiency, as well as creating products that can be applied to ruminants to optimize their efficiency while decreasing environmental burdens, naturally and healthily, for both the animals and their ecosystems."

KromaTiD Announces Launch of KromaTiD Pinpoint FISH TP53/CEP17 Kit for Synthetic Oligonucleotide-Based FISH Assay

Christopher Tompkins, KromaTiD's Chief Technology Officer says:  "Single-cell genomic measurements from KromaTiD have unique capabilities to analyze and understand the underlying genomic drivers of human disease.

Center for Contemporary Sciences (CCS) Partners with BICO to Modernize Medical Research and Drug Development

BICO is the world's leading bioconvergence company spearheading life sciences and medical technologies to shape the future of health. The two organizations will work closely to support the FDA Modernization Act of 2021 and combine efforts on other initiatives to improve human health and advance personalized medicine.

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test

CoSara's new multiplex test, the 12th CoSara assay to receive CDSCO approval, is built on the Company's patented CoPrimer™ technology and designed to detect and differentiate between HPV genotypes 16 and 18, while simultaneously detecting high-risk carcinogenic HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.

PubHive Helps Safety & Vigilance Teams Harness Signal Workflows

“Safety and vigilance teams have limited options today for managing safety signal workflows and information across various data sources, with most solutions being too manual, too rigid or incomplete,” said Raj Vaghela, President and CEO at PubHive Ltd.

NeoCura and PhoreMost Colloborate to Explore Novel Cancer Therapeutics

As part of the collaboration, PhoreMost's SITESEEKER® phenotypic screening platform and NeoCura's full-process RNA drug design platform will be used to investigate the cellular delivery and efficacy of encoded targeted peptides.

Caris Life Sciences and HotSpot Therapeutics Announce Collaboration to Advance Precision Medicine Development for Difficult-to-Drug Therapeutic Targets

"Our partnership with HotSpot Therapeutics aligns with our organizations' shared passion to bring comprehensive data to bear for patients and amplify our impact on precision medicine," said David Spetzler, M.S., Ph.D., MBA, President and Chief Scientific Officer of Caris. 

Avacta Update on AffiDX® SARS-CoV-2 Antigen Lateral Flow test and Detection of the Omicron Variant

Dr. Alastair Smith, Chief Executive of Avacta Group, commented: ““The continued high performance of the Affimer® reagent in the AffiDX® antigen test, despite the large number of mutations in the Omicron variant, is testament to the robustness of our platform technology.”

Indica Labs’ HALO AP® Platform Achieves CE-IVD Certification for Use in Primary Diagnosis

The HALO AP platform was developed by Indica Labs to address the specific needs of anatomic pathology labs by supporting a wide range of tissue-based workflows, including primary diagnosis, secondary consults, tumor boards, clinical trials, synoptic reporting, quantitative analytics.

GreenLight Biosciences Expands RTP Footprint for the Next Generation of Agricultural Products

The company has seven agricultural products in development with an addressable market of $6 billion that it plans to launch by 2026.
spot_img

Latest News

Accuredit Therapeutics and N1 Life Form a Joint Venture Named ‘Napoltec’, Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical...

"We are very pleased to establish a new joint venture, Napoltec, with N1 Life, which will be featuring complementary in mutually pursuing gene therapy drug development. The N1 Life team led by Dr. Zang and Prof. Wender has accumulated years of research and development experience in novel delivery systems.

FDA Releases Federal Interagency Working Group Scientific Opinions on Testing Methods for Asbestos in Talc-Containing Cosmetic Products

Release of the white paper concludes the efforts of the IWGACP. The FDA will consider the scientific opinions presented in the white paper, including having it peer-reviewed, as part of its overall efforts to help ensure the safety of talc-containing cosmetic products.

Hekka Labs Introduces the First Decentralized Chronic Disease Data Management Ecosystem in South Asia

Hekka has cemented initial partnerships with 3 Indian healthcare solution providers, Curisin, a healthcare company with a wide network of 30 million patients and 40,000 partnered doctors which as recently agreed to provide a minimum of 1.5 million medical records in 2022.

Impact NRS LLC Creates RumenEra Inc to Develop and Commercialize High-Impact Rumen Microbiome Applications in a Joint Collaboration with National Institute for Biotechnology in...

Mr. Salman continues "RumenEra is committed to the creation of a global reference standard for the rapid measurement of net feed efficiency, as well as creating products that can be applied to ruminants to optimize their efficiency while decreasing environmental burdens, naturally and healthily, for both the animals and their ecosystems."

Join Medical Device News Magazine's Mailing List: Receive a Weekly Recap of Device Industry News

spot_img